Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer

Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer

Objectives: To identify useful biomarkers by reviewing laboratory data for a predictor of the clinical course following treatment with radium-223 dichloride (Ra-223) in patients with metastatic castration-resistant prostate cancer. Methods: Eighteen metastatic castration-resistant prostate cancer pa...

Full description

Bibliographic Details
Main Authors: Gen Kawaguchi, Kohei Akazawa, Taro Ikeda, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama
Format: Article
Language:English
Published: SAGE Publishing 2023-04-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/20503121231168493

Internet

https://doi.org/10.1177/20503121231168493

Similar Items